Abstract
Thirteen 18β-glycyrrhetinic acid (GA) derivatives were obtained by reduction at C-11 position, oxidation at C-3 position and condensation at C-2 position of GA. Anti-microbial activity evaluation indicated that compounds 04, 05, 10, 13 and 14 showed more potent inhibitory activity against Staphylococcus aureus subsp. aureus, Staphylococcus epidermidis, Staphylococcus aureus than GA, especially compound 10, the inhibitory activity against Staphylococcus epidermidis was equaled with Ampicillin. Moreover, in vivo experiments exhibited that compound 10 also has anti-inflammatory effect, which could decrease about 59.69% TPA-induced ear edema of mice with the gavage treatment of 40.0 mg/mL. Immunohistochemistry results revealed that the effect of inhibition was related to inhibition of TPA-induced upregulation of the pro-inflammatory cytokines TNF-α and IL-1β. Furthermore, compound 10 also significantly decreased the expression level of p65 in NF-κB signaling pathway. In general, compound 10, both with antibacterial and anti-inflammatory activities, was expected to become a promising bio-functional agent.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.